Gaweco AS et al. |
Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527948
|
Tesi RJ et al. |
Conversion of pancreas transplants to FK 506 from CsA. |
1995 |
Transplant. Proc. |
pmid:8539828
|
Burke GW et al. |
Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism. |
1995 |
Transplant. Proc. |
pmid:8539872
|
Watanabe K et al. |
Fate of long-surviving allografts in tolerant recipients induced by fractionated lymphoid irradiation, donor bone marrow cell infusion, and FK 506 after retransplantation in dogs. |
1993 |
Transplant. Proc. |
pmid:7679813
|
Burke GW et al. |
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. |
1995 |
Transplant. Proc. |
pmid:8539874
|
Ueki M et al. |
Peritoneal-omental pouch as a site for islet allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7513462
|
Yasunami Y et al. |
Acceptance of donor-specific islet allografts in rat by intraportal preimmunization with islets and FK 506. |
1994 |
Transplant. Proc. |
pmid:7513467
|
Ryu S and Yasunami Y |
Prevention of immune rejection in rat islet allografts by continuous SC administration of FK 506 using a mini-osmotic pump. |
1991 |
Transplant. Proc. |
pmid:1703710
|
Mieles L et al. |
Oral glucose tolerance test in liver recipients treated with FK 506. |
1990 |
Transplant. Proc. |
pmid:1689894
|
Shapiro R et al. |
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636557
|
Okamoto M et al. |
Beneficial effect of multiple drug therapy including tacrolimus in clinical renal transplantation. |
2000 |
Transplant. Proc. |
pmid:11119905
|
Tian Ch et al. |
B- and T-lymphocyte attenuator/herpes virus entry mediator as early indicators for acute rejection following kidney transplantation. |
2013 Jan-Feb |
Transplant. Proc. |
pmid:23375291
|
Ochiai M et al. |
Islet toxicity of FK506 measured in canine autografts. |
1998 |
Transplant. Proc. |
pmid:9532224
|
Yao B et al. |
The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. |
2013 Jan-Feb |
Transplant. Proc. |
pmid:23375298
|
Ruiz MC et al. |
Effect of early versus delayed calcineurin inhibitor treatment on delayed graft function. |
2003 |
Transplant. Proc. |
pmid:12644096
|
Fraile P et al. |
Non-skin solid tumors as a cause of morbidity and mortality after liver transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715943
|
Roman A et al. |
Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans. |
2002 |
Transplant. Proc. |
pmid:11959227
|
Fung J et al. |
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7680146
|
Christians U et al. |
Interactions of FK 506 and cyclosporine metabolism. |
1991 |
Transplant. Proc. |
pmid:1721280
|
Andereggen E et al. |
Immunohistological study of islet xenograft rejection in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623420
|
Thomas FT et al. |
Comparative efficacy of immunosuppressive drugs in xenografting. |
1990 |
Transplant. Proc. |
pmid:1693452
|
McAlister VC et al. |
Cost of liver transplantation using tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636611
|
Braun F et al. |
Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk". |
2000 |
Transplant. Proc. |
pmid:11120281
|
Woodle ES et al. |
Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience. |
1999 |
Transplant. Proc. |
pmid:10576053
|
Sathyan S et al. |
A case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab. |
2009 |
Transplant. Proc. |
pmid:19917422
|
Kaminska D et al. |
Mycophenolate mofetil but not the type of calcineurin inhibitor (cyclosporine vs tacrolimus) influences the intragraft mRNA expression of cytokines in human kidney allograft biopsies by in situ RT-PCR analysis. |
2005 |
Transplant. Proc. |
pmid:15848526
|
Marzoa-Rivas R et al. |
Conversion of heart transplant patients from standard to sustained-release tacrolimus requires a dosage increase. |
2010 |
Transplant. Proc. |
pmid:20970591
|
Lodewijk L et al. |
Effect of liver regeneration on the pharmacokinetics of immunosuppressive drugs. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249561
|
Ohtsuka S et al. |
Effect of splenectomy on hamster-to-rat pancreas xenotransplantation. |
1994 |
Transplant. Proc. |
pmid:7518109
|
Takada Y et al. |
Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK506 and platelet activating factor antagonist. |
1998 |
Transplant. Proc. |
pmid:9838621
|
Porayko MK et al. |
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533358
|
Wang SC et al. |
FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. |
1991 |
Transplant. Proc. |
pmid:1721312
|
Nakamura K et al. |
Renal transplant recipient experiencing pneumatosis cystoides intestinalis: a case report. |
2003 |
Transplant. Proc. |
pmid:12591410
|
Akioka K et al. |
Abdominal pain is a critical complication of mycophenolate mofetil in renal transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12591411
|
Takeuchi H et al. |
Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters. |
2005 |
Transplant. Proc. |
pmid:15919452
|
Hohage H et al. |
Differential effects of cyclosporine and tacrolimus on mycophenolate pharmacokinetics in patients with impaired kidney function. |
2005 |
Transplant. Proc. |
pmid:15919453
|
Akita K and Mandel TE |
Effect of FK 506 and anti-CD4 monoclonal antibody treatment on xenografts of organ-cultured fetal pig pancreas and host lymphoid populations. |
1993 |
Transplant. Proc. |
pmid:7692650
|
Tanabe M et al. |
Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation. |
1995 |
Transplant. Proc. |
pmid:7533411
|
Masri MA |
Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts. |
1995 |
Transplant. Proc. |
pmid:7533412
|
Mieles LA et al. |
Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report. |
1991 |
Transplant. Proc. |
pmid:1721344
|
Nakazato P et al. |
Early experience with FK 506 induction immunosuppression--suggestion for using oral FK 506. |
1991 |
Transplant. Proc. |
pmid:1721345
|
Sarvary E et al. |
De novo Prograf versus de novo Advagraf: are trough level profile curves similar? |
|
Transplant. Proc. |
pmid:25131131
|
EscartÃn A et al. |
Analysis of pig-MAP after small bowel transplantation in pigs. |
1998 |
Transplant. Proc. |
pmid:9865377
|
Scantlebury VP et al. |
Outcome of kidney transplantation in African-Americans using tacrolimus. |
1997 |
Transplant. Proc. |
pmid:9414906
|
Oğütmen B et al. |
Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats. |
2006 |
Transplant. Proc. |
pmid:16549155
|
Branco KC et al. |
The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation. |
2012 |
Transplant. Proc. |
pmid:23026625
|
Sánchez-Fructuoso AI et al. |
Daclizumab induction as an immunosuppressive regimen for renal transplant recipients from non-heart-beating donors. |
2003 |
Transplant. Proc. |
pmid:12962759
|
Valente G et al. |
Conversion from twice-daily to once-daily tacrolimus in stable liver transplant patients: effectiveness in a real-world setting. |
2013 |
Transplant. Proc. |
pmid:23622676
|
Zhu Y et al. |
Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123011
|
Nishimoto Y et al. |
Real-time monitoring for detecting rejection using strain gauge force transducers in porcine small bowel transplantation. |
2004 |
Transplant. Proc. |
pmid:15050153
|
Miyazawa H et al. |
Graft immunomodulation by donor irradiation and recipient-specific bone marrow cells in rat small bowel transplantation. |
2002 |
Transplant. Proc. |
pmid:12072357
|
Platz KP et al. |
Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8907933
|
Coupes BM et al. |
Tacrolimus monotherapy in renal transplantation: four-year data. |
2002 |
Transplant. Proc. |
pmid:12176506
|
Iaria G et al. |
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. |
2011 |
Transplant. Proc. |
pmid:21620043
|
Guy S et al. |
Successful treatment of acute severe graft-versus-host-disease in a pancreas-after-kidney transplant recipient: case report. |
2014 |
Transplant. Proc. |
pmid:25179161
|
Imanishi M et al. |
Induction of tolerance by intrathymic injection of donor bone marrow cells in the rat: simultaneous heart and skin allograft model. |
1994 |
Transplant. Proc. |
pmid:7520615
|
Lieberman KV et al. |
FK 506 is a direct glomeruloconstrictor, as determined by electrical resistance pulse sizing (ERPS). |
1991 |
Transplant. Proc. |
pmid:1721376
|
Demetris AJ et al. |
Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703360
|
Stratta RJ |
Optimal immunosuppression in pancreas transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083263
|
Rastellini C et al. |
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083278
|
Walgenbach KJ et al. |
Immunocytes of composite tissue allografts express elevated levels of TGF beta mRNA and protein during chronic rejection. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123418
|
Hesse CJ et al. |
The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation. |
2001 |
Transplant. Proc. |
pmid:11377487
|
Platz KP et al. |
Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients. |
1996 |
Transplant. Proc. |
pmid:8962235
|
Uchida K et al. |
Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176556
|
Iwamoto H et al. |
Early steroid withdrawal in adult kidney transplantation at a single center. |
2012 |
Transplant. Proc. |
pmid:22310609
|
Shinozuka H et al. |
Effect of FK 506 on experimental liver carcinogenesis. |
1991 |
Transplant. Proc. |
pmid:1721407
|
Cai X et al. |
Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin. |
1992 |
Transplant. Proc. |
pmid:1379759
|
Vincenti F |
Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267172
|
Ash MM and Jolly PS |
A Case Report of the Resolution of Multiple Recalcitrant Verrucae in a Renal Transplant Recipient After a Mycophenolate Mofetil Dose Reduction. |
|
Transplant. Proc. |
pmid:28104140
|
Zhou S et al. |
Tacrolimus enhances the invasion potential of hepatocellular carcinoma cells and promotes lymphatic metastasis in a rat model of hepatocellular carcinoma: involvement of vascular endothelial growth factor-C. |
2011 |
Transplant. Proc. |
pmid:21911157
|
Sicilia-Castro D et al. |
Reconstruction of a severe facial defect by allotransplantation in neurofibromatosis type 1: a case report. |
2011 |
Transplant. Proc. |
pmid:21911174
|
Kiberd BA et al. |
Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period. |
2005 |
Transplant. Proc. |
pmid:15964408
|
Lagget M et al. |
Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients. |
1998 |
Transplant. Proc. |
pmid:9723312
|
Hummel AD et al. |
Application of artificial neural networks in renal transplantation: classification of nephrotoxicity and acute cellular rejection episodes. |
2010 |
Transplant. Proc. |
pmid:20304167
|
Kanatani T et al. |
Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival. |
2005 |
Transplant. Proc. |
pmid:15964421
|
Gnatta D et al. |
Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study. |
2010 |
Transplant. Proc. |
pmid:20304169
|
Holt DW et al. |
Therapeutic monitoring of sirolimus: its contribution to optimal prescription. |
2003 |
Transplant. Proc. |
pmid:12742490
|
Trotter JF |
Sirolimus in liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12742496
|
Ventura E et al. |
Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring. |
2009 |
Transplant. Proc. |
pmid:19328963
|
Sundberg AK et al. |
Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes. |
2002 |
Transplant. Proc. |
pmid:12176640
|
Li ZY et al. |
Analytical performance of the Abbott Architect i2000 tacrolimus assay in Chinese patients after renal transplantation. |
2010 |
Transplant. Proc. |
pmid:21168731
|
Ojogho ON et al. |
Mycophenolate mofetil without antibody induction in pediatric renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176641
|
van der Laan LJ et al. |
Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimus. |
2010 |
Transplant. Proc. |
pmid:21168740
|
Jiang H et al. |
Prolonged cardiac allograft survival in sensitized rats by low-dose FK 506 in combination with splenectomy. |
1991 |
Transplant. Proc. |
pmid:1721439
|
Veroux M et al. |
Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients. |
2006 |
Transplant. Proc. |
pmid:16757256
|
Sato K et al. |
Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine. |
1991 |
Transplant. Proc. |
pmid:1721440
|
Makowka L et al. |
The effect of FK-506 on hyperacute rejection in presensitized rats. |
1987 |
Transplant. Proc. |
pmid:2445082
|
Odocha O et al. |
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7689268
|
Ochiai T et al. |
Effects of FK-506 on xenotransplantation of the heart and skin in a mouse-rat combination. |
1987 |
Transplant. Proc. |
pmid:2445083
|
Markus BH et al. |
Daclizumab induction therapy in combination with tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267354
|
Reiner J et al. |
After Intestinal Transplantation Kidney Function Is Impaired by Downregulation of Epithelial Ion Transporters in the Ileum. |
2016 |
Transplant. Proc. |
pmid:27109987
|
Rao B et al. |
Use of Everolimus After Multivisceral Transplantation: A Report of Two Cases. |
2016 |
Transplant. Proc. |
pmid:27109983
|
Sigal NH et al. |
Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A. |
1991 |
Transplant. Proc. |
pmid:1712132
|
González MG et al. |
Comparison of post-liver transplantation electrocardiographic alterations between cyclosporine- and tacrolimus-treated patients. |
1999 |
Transplant. Proc. |
pmid:10500652
|
Chang HK et al. |
Ten-Year Experience With Bowel Transplantation at Seoul St. Mary's Hospital. |
2016 |
Transplant. Proc. |
pmid:27109981
|
Morris-Stiff G et al. |
Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636499
|
Eghtesad B et al. |
Use of tacrolimus as the primary immunosuppression after renal transplant in Native Americans and Hispanics. |
1998 |
Transplant. Proc. |
pmid:9636500
|
Scholler G et al. |
Comparison of cyclosporine A and FK506 with regard to complaints and psychosocial characteristics before and after liver transplantation. |
1997 |
Transplant. Proc. |
pmid:9270822
|
Pichlmayr R et al. |
Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study. |
1997 |
Transplant. Proc. |
pmid:9270825
|
Fisher A et al. |
Gastrointestinal toxicity associated with FK 506 in liver transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7527947
|